UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complication in overweight patients with type 2 diabetes (UKPDS34 )[J]. Lancet, 1998, 352: 854.
Wolford J K, Gruber J D, Ossow ski V M, et al. C-reactive protein promoter polymorphism is associated with type 2 diabetes mellitus in pima Indians[J]. Mol Genet Metab, 2003, 78: 136.
[6]
Twig G, Afek A, Shamiss A, et al. White blood cells count and incidence of type 2 diabetes in young men[J]. Diabetes Care, 2013, 36(2):276.
[7]
Woodm an R J, Watts G F, Pndder I B, et al. Leukocyte count and vascular function in type 2 diabetes subjects with treated hypertension[J]. Atherosclerosis, 2002, 163(1): 175.
Greisenegger S, Endler G, Hsieh K, et al. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events[J]. Stroke, 2004, 35(7):1688.
Xie L H, Ahn E M, Akao T, et al. Transformation of arctiin to estrogenic and antiestrogenic substances by human intestinal bacteria[J]. Chem Pharm Bull, 2003, 51(4): 378.
Matsumoto K, Kanmatsuse K. Elevated vascular endothelial growth factor levels in the urine of patients with minimalchange nepbortic syndrome[J]. Clin Nephrol, 2001, 55(4): 269.
[19]
Duh E, Aiello L P. Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox[J]. Diabetes, 1999, 48(10): 1899.
[20]
Akeson A, Hermana, Winginton D, et al. Endothelial cell activation in a VEGF-A gadient: relevance to cell fate decisions[J]. Microvascular Res, 2010, 80(1): 65.
[21]
Zhao Q, Egashira K, Inoue S. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis[J]. Circulation, 2002, 105(9): 1110.
[22]
Valabhji J, Dhanjil S, Nicolaides A N, et al. Correlation between carotid artery distensibility and serum vascular endothelial growth factor concentration in type 1 diabetic subjects and nondiabetic subjects[J]. Metabolism, 2001, 50(7): 825.
[23]
Inoue M, Itoh H, Ueda M, et al. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions[J]. Circulation, 1998, 98 (20): 108.
[24]
Tsai J C, Sheu S H, Chiu H C, et al. Association of peripheral total and differential leukocyte counts with metabolic syndrome and risk of ischemic cardiovascular diseases in patients with type 2 diabetes mllitus [J]. Diabetes Metab Res Rev, 2007, 23(2): 111.
